CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
High ImpactOriginal article

Novartis licenses Abogen mRNA autoimmune drug in $7.8B deal

PartnershipPositive
AI Analysis

Summary

Novartis has licensed an mRNA autoimmune drug from Abogen in a $7.8 billion deal, representing a significant partnership in the mRNA therapeutic space.

Importance:8/10
Sentiment:
0.80
licensingpartnershipmRNAautoimmunedeal
Related Companies

Read the original article

Published by yahoo_finance on October 2, 2026 1:40 PM

Read Original